Check out this story: GSK Dupes Migraine Sufferers
Hi Folks,
I'd like to share with you a story that was recently posted on the Prescription Access Litigation Blog entitled "GlaxoSmithKline sets out to dupe migraine sufferers with Treximet smoke and mirrors."
GlaxoSmithKline (NYSE:GSK) sells a popular brand-name prescription drug for migraines, Imitrex. 2007 U.S. sales of Imitrex were... Read more
Add comment
| 7 Comments
|
Notify me when there are new comments
